Fat loss monitor hbf 306c

Demographics (age, sex, race/ethnicity, education level), medical conditions, medications, family history, and adverse events during the study were obtained by self-report. Height and weight were measured without shoes. Percent body fat was estimated from bioimpedance (Omron Fat Loss Monitor HBF-306C, OMRON Healthcare, Inc., Lake Forest, IL), blood pressure and heart rate were measured via an automated instrument (Omron HEM-712C). Circumferences of the waist and hip were measured using a plastic tape over light clothing.

Metabolic health was measured using several tests, including: body fat percentage, BMI, systolic and diastolic blood pressure, hemoglobin A1C (HbA1C), high density lipoproteins (HDL), and non-high density lipoproteins (non-HDL). Body fat percentage was measured using an OMRON Fat Loss Monitor HBF-306C bioelectric impedance analysis tool (Omron Healthcare, Inc., Lake Forest, IL). Blood pressure was measured using an OMRON HEM-7783 vital signs monitor (Omron Healthcare, Inc., Lake Forest, IL). HDL, non-HDL, and HbA1C were measured from blood taken from a finger prick. Blood samples were immediately processed using Alere Afinion HbA1C 1115015 Tests and Alere Cholestech LDX system-Lipid Profile 10–989 Tests (Alere Inc., Waltham, MA). Results were scored based on age and gender, standardized on the 0–100 point scale, and averaged for a total metabolic health score.